FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
Clinical trial NCT03841110 · COMPLETED
Trial details
- NCT number
- NCT03841110
- Sponsor
- Fate Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-15
- Primary completion
- 2022-11-15
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.